Evidence map›Paper›PMID 24276928›Full record

ArticleJournal of clinical immunology2014

Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India.

Amit Rawat, Surjit Singh, Deepti Suri, Anju Gupta, Biman Saikia, Ranjana Walker Minz, Shobha Sehgal, Kim Vaiphei, C Kamae, K Honma and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Clinical and demographic pattern of chronic granulomatous disease (CGD) from a multicenter perspective: Malaysia's experience over 26 years.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Clinical and Laboratory Profiles of 17 Cases of Chronic Granulomatous Disease in North India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2021
    Article
  12. Article
  13. Article
  14. Blood advances · 2019
    Article
  15. Review
  16. Article
  17. Preliminary study on chronic granulomatous disease in Sri Lanka.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Amit RawatAdvanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Surjit Singh
Deepti Suri
Anju Gupta
Biman Saikia
Ranjana Walker Minz
Shobha Sehgal
Kim Vaiphei
C Kamae
K Honma
N Nakagawa
K Imai
S Nonoyama
K Oshima
N Mitsuiki
O Ohara
Koon-Wing Chan
Yu Lung Lau
Post Graduate Institute of Medical Education and Research · INNational Defense Medical College · JPKazusa DNA Research Institute · JPQueen Mary Hospital · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) results from an inherited defect in the phagocytic cells of the immune system. It is a genetically heterogenous disease caused by defects in one of the five major subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. There is a paucity of data from India on CGD. We herein describe the clinical features in 17 children with CGD from a single tertiary referral center in India. A detailed analysis of the clinical features, laboratory investigations and outcome of 17 children 7 with X-linked (XL) and 10 with autosomal recessive (AR) form was performed. Diagnosis of CGD was based on an abnormal granulocyte oxidative burst evaluated by either Nitroblue Tetrazolium (NBT) test or flow cytometry based Dihyrorhodamine 123 assay or both. The molecular diagnosis was confirmed by genetic mutation analysis in 13 cases. The mean age at diagnosis and the age at onset of symptoms was significantly lower in children diagnosed with XL- CGD compared those with AR disease. Mutations were detected in CYBB gene in 6 patients with XL-CGD and NCF-1 gene mutations were observed in 7 cases of AR- CGD. The course and outcome of the disease was much worse in children diagnosed with X-linked form of disease compared to AR forms of the disease; 4/7 (57%) children with X-CGD were dead at the time of data analysis. This is one of the largest series on chronic granulomatous disease from any developing country.

Indexed as

Tertiary Care CentersAge of OnsetCause of DeathChildChild, PreschoolFemaleFollow-Up StudiesGranulomatous Disease, ChronicHospital MortalityHumansIndiaInfantInfant, NewbornInfectionsMaleMutation

Identifiers

PMID24276928
OpenAlexW2064383982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.